Lumos Pharma, Inc. (LUMO) Reports In-Line Q2 EPS

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 11/4/2026

1. AMD
2. BKNG
3. AMGN
4. DOX
5. DUOL
6. SWKS
7. ANET
8. SPY
9. XYZ
10. CVS

Go back to Lumos Pharma, Inc. (LUMO) Reports In-Line Q2 EPS

Lumos Pharma Reports Second Quarter 2021 Financial Results and Provides Clinical and Corporate Updates

August 5, 2021 8:00 AM EDT

Lumos Pharma strengthens leadership team with promotion of John McKew, PhD to President, and addition of David B. Karpf, MD as Chief Medical Officer and Mark Bach, MD, PhD to Advisory Board

Screening and enrollment of OraGrowtH210 and OraGrowtH212 Trials progress

AUSTIN, Texas, Aug. 05, 2021 (GLOBE NEWSWIRE) -- Lumos Pharma, Inc. (NASDAQ: LUMO), a clinical-stage... More